Literature DB >> 11583980

Differential cellular expression of neurotrophins in cortical tubers of the tuberous sclerosis complex.

R Kyin1, Y Hua, M Baybis, B Scheithauer, D Kolson, E Uhlmann, D Gutmann, P B Crino.   

Abstract

Neurotrophins and their receptors modulate cerebral cortical development. Tubers in the tuberous sclerosis complex (TSC) are characterized histologically by disorganized cortical cytoarchitecture and thus, we hypothesized that expression of neurotrophin mRNAs and proteins might be altered in tubers. Using in situ transcription and mRNA amplification to probe cDNA arrays, we found that neurotrophin-3 (NT3) and trkB mRNA expression were reduced whereas neurotrophin-4 (NT4) and trkC mRNA expression were increased in whole tuber sections. Alterations in mRNA abundance were defined in single microdissected dysplastic neurons (DNs) and giant cells (GCs). NT3 mRNA expression was reduced in GCs and trkB mRNA expression was reduced in DNs. NT4 mRNA expression was increased in DNs and trkC mRNA expression was increased in both DNs and GCs. In three patients, TSC2 locus mutations were confirmed and the mean tuberin mRNA expression levels was reduced across all nine cases. Consistent with these observations, NT3 mRNA expression was reduced but trkC mRNA expression was increased in vitro in human NTera2 neurons (NT2N) transfected with a tuberin antisense construct that reduced tuberin expression. Western analysis of tuber homogenates and computer-assisted densitometry of immunolabeled sections confirmed the neurotrophin mRNA expression data in whole sections and single neurotrophin immunoreactive cells. We conclude that alterations in NT4/trkB and NT3/trkC expression may contribute to tuber formation during brain development as downstream effects of the hamartin and tuberin pathway in TSC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11583980      PMCID: PMC1850517          DOI: 10.1016/S0002-9440(10)62539-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  52 in total

1.  Pathology of tuberous sclerosis. Neuropathologic aspects.

Authors:  E P Richardson
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

2.  Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons.

Authors:  S J Pleasure; C Page; V M Lee
Journal:  J Neurosci       Date:  1992-05       Impact factor: 6.167

3.  Epilepsy surgery in children with tuberous sclerosis complex: presurgical evaluation and outcome.

Authors:  S Koh; P Jayakar; C Dunoyer; S E Whiting; T J Resnick; L A Alvarez; G Morrison; J Ragheb; A Prats; P Dean; J Gilman; M S Duchowny
Journal:  Epilepsia       Date:  2000-09       Impact factor: 5.864

4.  Netrin-1 promotes thalamic axon growth and is required for proper development of the thalamocortical projection.

Authors:  J E Braisted; S M Catalano; R Stimac; T E Kennedy; M Tessier-Lavigne; C J Shatz; D D O'Leary
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

5.  Mice lacking NT-3, and its receptor TrkC, exhibit profound deficiencies in CNS glial cells.

Authors:  M A Kahn; S Kumar; D Liebl; R Chang; L F Parada; J De Vellis
Journal:  Glia       Date:  1999-04       Impact factor: 7.452

6.  Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.

Authors:  S L Dabora; S Jozwiak; D N Franz; P S Roberts; A Nieto; J Chung; Y S Choy; M P Reeve; E Thiele; J C Egelhoff; J Kasprzyk-Obara; D Domanska-Pakiela; D J Kwiatkowski
Journal:  Am J Hum Genet       Date:  2000-12-08       Impact factor: 11.025

7.  TrkB receptor ligands promote activity-dependent inhibitory synaptogenesis.

Authors:  F J Seil; R Drake-Baumann
Journal:  J Neurosci       Date:  2000-07-15       Impact factor: 6.167

8.  Traumatic brain injury alters the molecular fingerprint of TUNEL-positive cortical neurons In vivo: A single-cell analysis.

Authors:  D M O'Dell; R Raghupathi; P B Crino; J H Eberwine; T K McIntosh
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

9.  The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination.

Authors:  G Benvenuto; S Li; S J Brown; R Braverman; W C Vass; J P Cheadle; D J Halley; J R Sampson; R Wienecke; J E DeClue
Journal:  Oncogene       Date:  2000-12-14       Impact factor: 9.867

10.  In situ transcription: specific synthesis of complementary DNA in fixed tissue sections.

Authors:  L H Tecott; J D Barchas; J H Eberwine
Journal:  Science       Date:  1988-06-17       Impact factor: 47.728

View more
  8 in total

1.  Early progenitor cell marker expression distinguishes type II from type I focal cortical dysplasias.

Authors:  Ksenia A Orlova; Victoria Tsai; Marianna Baybis; Gregory G Heuer; Sanjay Sisodiya; Maria Thom; Kevin Strauss; Eleonora Aronica; Phillip B Storm; Peter B Crino
Journal:  J Neuropathol Exp Neurol       Date:  2010-08       Impact factor: 3.685

2.  Enhanced epidermal growth factor, hepatocyte growth factor, and vascular endothelial growth factor expression in tuberous sclerosis complex.

Authors:  Whitney E Parker; Ksenia A Orlova; Gregory G Heuer; Marianna Baybis; Eleonora Aronica; Michael Frost; Michael Wong; Peter B Crino
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

Review 3.  The neurobiology of the tuberous sclerosis complex.

Authors:  Leah Marcotte; Peter B Crino
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 4.  Identifying targets for preventing epilepsy using systems biology.

Authors:  Jeffrey A Loeb
Journal:  Neurosci Lett       Date:  2011-03-04       Impact factor: 3.046

5.  Expression of the neural stem cell markers NG2 and L1 in human angiomyolipoma: are angiomyolipomas neoplasms of stem cells?

Authors:  So Dug Lim; William Stallcup; Benjamin Lefkove; Baskaran Govindarajan; Kit Sing Au; Hope Northrup; Deborah Lang; David E Fisher; Avani Patel; Mahul B Amin; Jack L Arbiser
Journal:  Mol Med       Date:  2007 Mar-Apr       Impact factor: 6.354

6.  Gene expression analysis of tuberous sclerosis complex cortical tubers reveals increased expression of adhesion and inflammatory factors.

Authors:  Karin Boer; Peter B Crino; Jan A Gorter; Mark Nellist; Floor E Jansen; Wim G M Spliet; Peter C van Rijen; Floyd R A Wittink; Timo M Breit; Dirk Troost; Wytse J Wadman; Eleonora Aronica
Journal:  Brain Pathol       Date:  2009-10-08       Impact factor: 6.508

7.  Fetal brain mTOR signaling activation in tuberous sclerosis complex.

Authors:  Victoria Tsai; Whitney E Parker; Ksenia A Orlova; Marianna Baybis; Anthony W S Chi; Benjamin D Berg; Jacqueline F Birnbaum; Jacqueline Estevez; Kei Okochi; Harvey B Sarnat; Laura Flores-Sarnat; Eleonora Aronica; Peter B Crino
Journal:  Cereb Cortex       Date:  2012-10-18       Impact factor: 5.357

8.  Coding and small non-coding transcriptional landscape of tuberous sclerosis complex cortical tubers: implications for pathophysiology and treatment.

Authors:  James D Mills; Anand M Iyer; Jackelien van Scheppingen; Anika Bongaarts; Jasper J Anink; Bart Janssen; Till S Zimmer; Wim G Spliet; Peter C van Rijen; Floor E Jansen; Martha Feucht; Johannes A Hainfellner; Pavel Krsek; Josef Zamecnik; Katarzyna Kotulska; Sergiusz Jozwiak; Anna Jansen; Lieven Lagae; Paolo Curatolo; David J Kwiatkowski; R Jeroen Pasterkamp; Ketharini Senthilkumar; Lars von Oerthel; Marco F Hoekman; Jan A Gorter; Peter B Crino; Angelika Mühlebner; Brendon P Scicluna; Eleonora Aronica
Journal:  Sci Rep       Date:  2017-08-14       Impact factor: 4.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.